DE3688450T2 - 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel. - Google Patents
3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel.Info
- Publication number
- DE3688450T2 DE3688450T2 DE8686115076T DE3688450T DE3688450T2 DE 3688450 T2 DE3688450 T2 DE 3688450T2 DE 8686115076 T DE8686115076 T DE 8686115076T DE 3688450 T DE3688450 T DE 3688450T DE 3688450 T2 DE3688450 T2 DE 3688450T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- optionally substituted
- stands
- chem
- pyridazine derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU854155A HU195645B (en) | 1985-10-30 | 1985-10-30 | Process for preparing novel 3(2h)-pyridazinone derivatives and pharmaceutical compositions comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3688450D1 DE3688450D1 (de) | 1993-06-24 |
DE3688450T2 true DE3688450T2 (de) | 1993-09-09 |
Family
ID=10967128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686115076T Expired - Fee Related DE3688450T2 (de) | 1985-10-30 | 1986-10-30 | 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4826845A (de) |
EP (1) | EP0220735B1 (de) |
JP (1) | JPS62161768A (de) |
AT (1) | ATE89558T1 (de) |
AU (1) | AU589698B2 (de) |
CA (1) | CA1317598C (de) |
DE (1) | DE3688450T2 (de) |
ES (1) | ES2058054T3 (de) |
HU (1) | HU195645B (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE62890B1 (en) * | 1988-12-06 | 1995-03-08 | Hafslund Nycomed Pharma | New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure |
GB9015764D0 (en) * | 1990-07-18 | 1990-09-05 | Fujisawa Pharmaceutical Co | Pyrazolopyridine compound and processes for preparation thereof |
CN1038249C (zh) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | 含有二氢哒嗪酮及其相关化合物的杀菌组合物 |
HU224067B1 (hu) * | 1995-05-29 | 2005-05-30 | Gyógyszerkutató Intézet Kft. | 3(2H)-Piridazinon-származékok és e vegyületeket tartalmazó gyógyszerkészítmények |
JPH11508267A (ja) * | 1995-06-26 | 1999-07-21 | 藤沢薬品工業株式会社 | ピラゾール化合物および医薬組成物 |
US6447821B1 (en) * | 1996-05-30 | 2002-09-10 | Warner-Lambert Company | Sugar coated products and process for preparing the same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT204560B (de) | 1957-12-14 | 1959-07-25 | Chemie Linz Ag | Verfahren zur Herstellung von neuen Pyridazinderivaten |
US2938902A (en) | 1959-04-24 | 1960-05-31 | American Cyanamid Co | Novel pyridazinones and methods of preparing same |
FR5027M (de) * | 1966-01-25 | 1967-04-24 | ||
US3658814A (en) * | 1970-03-17 | 1972-04-25 | Sandoz Ag | 2-(omega-chloroalkyl)-6-aryl substituted-4 5-dihydropyridazin(2h)-3-one |
BE752074A (en) * | 1970-06-16 | 1970-12-16 | Sandoz Sa | Antiinflammatory pyridazines |
BE791098A (fr) * | 1971-11-10 | 1973-05-08 | Sandoz Sa | Nouveaux derives de la pyridazine, leur preparation et leur applicationcomme medicaments |
US4304777A (en) * | 1979-08-30 | 1981-12-08 | Sterling Drug Inc. | 6-(Pyridinyl)-3(2H)-pyridazinones and their use as cardiotonics |
US4298609A (en) * | 1979-08-30 | 1981-11-03 | Sterling Drug Inc. | 4,5-Dihydro-6-(4-pyridinyl)-3-pyridazinol and salts, their preparation and use as blood pressure lowering agents |
JPS5728054A (en) * | 1980-07-29 | 1982-02-15 | Morishita Seiyaku Kk | Pyridazinone derivative |
JPS5742676A (en) * | 1980-08-29 | 1982-03-10 | Morishita Seiyaku Kk | Pyridazinone derivative |
JPS58146571A (ja) * | 1982-02-25 | 1983-09-01 | Morishita Seiyaku Kk | ウレア誘導体およびその製造法 |
DE3302021A1 (de) * | 1983-01-22 | 1984-07-26 | Basf Ag, 6700 Ludwigshafen | 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung |
US4521416A (en) * | 1983-03-22 | 1985-06-04 | Warner-Lambert Company | 4,5-Dihydro-6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones and 6-[(substituted)-1H-imidazol-4-yl or 5-yl]-3(2H)-pyridazinones |
US4666902A (en) * | 1983-06-20 | 1987-05-19 | Cassella Aktiengesellschaft | Tetrahydropyridazinone derivatives, processes for their preparation and their use |
-
1985
- 1985-10-30 HU HU854155A patent/HU195645B/hu not_active IP Right Cessation
-
1986
- 1986-10-29 US US06/924,445 patent/US4826845A/en not_active Expired - Fee Related
- 1986-10-29 AU AU64496/86A patent/AU589698B2/en not_active Ceased
- 1986-10-30 CA CA000521779A patent/CA1317598C/en not_active Expired - Fee Related
- 1986-10-30 JP JP61257138A patent/JPS62161768A/ja active Granted
- 1986-10-30 EP EP86115076A patent/EP0220735B1/de not_active Expired - Lifetime
- 1986-10-30 DE DE8686115076T patent/DE3688450T2/de not_active Expired - Fee Related
- 1986-10-30 ES ES86115076T patent/ES2058054T3/es not_active Expired - Lifetime
- 1986-10-30 AT AT86115076T patent/ATE89558T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA1317598C (en) | 1993-05-11 |
EP0220735A2 (de) | 1987-05-06 |
JPS641475B2 (de) | 1989-01-11 |
ATE89558T1 (de) | 1993-06-15 |
JPS62161768A (ja) | 1987-07-17 |
ES2058054T3 (es) | 1994-11-01 |
AU589698B2 (en) | 1989-10-19 |
AU6449686A (en) | 1987-05-07 |
US4826845A (en) | 1989-05-02 |
HU195645B (en) | 1988-06-28 |
HUT43047A (en) | 1987-09-28 |
EP0220735A3 (en) | 1988-06-15 |
DE3688450D1 (de) | 1993-06-24 |
EP0220735B1 (de) | 1993-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IE842633L (en) | Blood-pressure lowering piperazines | |
DE3676179D1 (de) | N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
DE3884555D1 (de) | Octahydronaphthalenoxim-derivate fuer cholesterolsynthese-inhibierung, verfahren fuer deren herstellung und diese enthaltende zusammenstellungen. | |
DE3882438D1 (de) | Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
DE3688450D1 (de) | 3(2h)-pyridazinonderivate, verfahren und zwischenprodukte zu deren herstellung und diese und/oder andere 3(2h)-pyridazinonderivate enthaltende heilmittel. | |
PT85688A (de) | Neue naphthylderivate diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
ATE108440T1 (de) | Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
DE3864707D1 (de) | Benzoxazin-derivate und verfahren zu ihrer herstellung. | |
EP0086416A3 (de) | Corynanthein-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
DE3480839D1 (de) | Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung. | |
IL72682A0 (en) | New derivatives of 4-phenyl-4-oxo-buten-2-oic acid,the process for preparing them,their application as medicaments and the compositions containing them | |
DE3574471D1 (de) | 1,6-naphthyridin-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. | |
DK163055C (da) | Analogifremgangsmaade til fremstilling af 2-dipropylamino-(5 eller 7)-formylamino-6-hydroxy-1,2,3,4-tetrahydronaphthalen og farmakologisk acceptable syreadditionssalte deraf | |
ES8303393A1 (es) | Un procedimiento para preparar derivados del acido ascorbico. | |
ATE18667T1 (de) | Aethenylimidazol-derivate, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen, bei deren herstellung verwendbare zwischenprodukte und verfahren zu deren herstellung. | |
ATE35133T1 (de) | N-substituierte (bis(hydroxymethyl)-methyl>isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
DE3887579D1 (de) | Mercapto-substituierte Pyridine und Verfahren zu deren Herstellung. | |
DE3786507D1 (de) | Heterocyclische propenamid-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE18556T1 (de) | Phenylalkyloxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre anwendung und sie enthaltende arzneimittel. | |
DE3671016D1 (de) | Thiazolidinderivate und verfahren zu ihrer herstellung. | |
ATE34740T1 (de) | (bis(hydroxymethyl)methyl)-isochinolinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten. | |
DE3674250D1 (de) | Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung. | |
ATE36154T1 (de) | 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
DE68907857D1 (de) | Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE6063T1 (de) | Cycloalkano-thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |